What Is Mytesi?

Mytesi is the only FDA-approved treatment for noninfectious diarrhea in adults who are living with HIV and on antiretroviral therapy (ART).1

What Is Mytesi?

Mytesi is the only FDA-approved treatment for noninfectious diarrhea in adults who are living with HIV and on antiretroviral therapy (ART).1

Mytesi can effectively reduce noninfectious diarrhea

It has a low risk of constipation

How do I take Mytesi?2

When taking Mytesi daily, most patients continue to see improvement in their symptoms even up to 20 weeks after starting treatment. It’s important to continue taking Mytesi daily to see these improvements, even if the symptom relief seems gradual.

Crofelemer, the active ingredient in Mytesi, is a botanical (plant-based) drug substance extracted and purified from the red bark sap of the Croton lechleri tree found in the Amazon rainforest

Mytesi works differently than other
standard treatments for diarrhea.

Mytesi works differently than other standard treatments for diarrhea.
See How Mytesi Works

References: 1. Gehrig M, Clay P, Perry R, et al. Actual versus perceived use of pharmacokinetic (primarily absorption) influential OTC agents and ART tolerability in a nationwide matched cohort of HIV patients and their healthcare providers. Presented at: ID Week 2016; October 28, 2016; New Orleans, LA. Abstract 1514. 2. Mytesi [package insert]. San Francisco, CA: Napo Pharmaceuticals Inc; 2018.